BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22156858)

  • 1. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
    Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
    Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.
    Costantini A; Marinelli K; Biagioni G; Monachetti A; Ferreri ML; Butini L; Montroni M; Manzin A; Bagnarelli P
    BMC Infect Dis; 2011 Nov; 11():310. PubMed ID: 22054111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi.
    Aoudjane S; Chaponda M; González Del Castillo AA; O'Connor J; Noguera M; Beloukas A; Hopkins M; Khoo S; van Oosterhout JJ; Geretti AM
    Clin Infect Dis; 2014 Dec; 59(11):1618-26. PubMed ID: 25100867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy.
    Weissmann L; Picone CM; Gouvêa MSG; Ferreira PRA; Viana MSVB; Pinho JRR; Cassenote AJF; Segurado AC
    Braz J Infect Dis; 2019; 23(6):441-450. PubMed ID: 31715124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.
    Ocama P; Seremba E; Apica B; Opio K
    Afr Health Sci; 2015 Jun; 15(2):328-33. PubMed ID: 26124776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection.
    Chung RT; King WC; Ghany MG; Lisker-Melman M; Hinerman AS; Khalili M; Sulkowski M; Jain MK; Choi EK; Nalesnik MA; Bhan AK; Cloherty G; Wong DK; Sterling RK;
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):125-135.e8. PubMed ID: 34973459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern India.
    Saha D; Pal A; Biswas A; Panigrahi R; Sarkar N; Sarkar J; Pal M; Guha SK; Saha B; Chakrabarti S; Chakravarty R
    PLoS One; 2013; 8(8):e73613. PubMed ID: 24023688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in Botswana.
    Phinius BB; Anderson M; Gobe I; Mokomane M; Choga WT; Phakedi B; Ratsoma T; Mpebe G; Makhema J; Shapiro R; Lockman S; Musonda R; Moyo S; Gaseitsiwe S
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus clinical and virologic characteristics in an HIV perinatal transmission study in sub-Saharan Africa.
    Bhattacharya D; Guo R; Tseng CH; Emel L; Sun R; Zhang TH; Chiu SH; Stranix-Chibanda L; Chipato T; Ship H; Mohtashemi NZ; Kintu K; Manji KP; Moodley D; Maldonado Y; Currier JS; Thio CL
    AIDS; 2024 Mar; 38(3):329-337. PubMed ID: 37861675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of liver transplantation in human immunodeficiency virus/hepatitis B virus coinfected patients in China.
    Tang J; Weng R; Fang T; Zhang K; Yan X; Jin X; Xie L; Zhao D
    BMC Infect Dis; 2024 Apr; 24(1):383. PubMed ID: 38589801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B viral replication markers and hepatic fibrosis in untreated chronic hepatitis B virus infection with and without HIV coinfection in Zambia.
    Muula GK; Bosomprah S; Sinkala E; Nsokolo B; Musonda T; Hamusonde K; Bhattacharya D; Lauer G; Chung RT; Mulenga LB; Wandeler G; Vinikoor MJ
    AIDS; 2023 Nov; 37(13):2015-2020. PubMed ID: 37467044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.
    Singh KP; Crane M; Audsley J; Avihingsanon A; Sasadeusz J; Lewin SR
    AIDS; 2017 Sep; 31(15):2035-2052. PubMed ID: 28692539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV outcomes in Hepatitis B virus coinfected individuals on HAART.
    Chun HM; Mesner O; Thio CL; Bebu I; Macalino G; Agan BK; Bradley WP; Malia J; Peel SA; Jagodzinski LL; Weintrob AC; Ganesan A; Bavaro M; Maguire JD; Landrum ML;
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):197-205. PubMed ID: 24694929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of HBV and HIV co-infection in children and outcomes following highly active antiretroviral therapy (HAART) in Uyo, South-South Nigeria.
    Ikpeme EE; Etukudo OM; Ekrikpo UE
    Afr Health Sci; 2013 Dec; 13(4):955-61. PubMed ID: 24940318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.
    Ndow G; Gore ML; Shimakawa Y; Suso P; Jatta A; Tamba S; Sow A; Touré-Kane C; Sadiq F; Sabally S; Njie R; Thursz MR; Lemoine M
    PLoS One; 2017; 12(6):e0179025. PubMed ID: 28614401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.
    Chun HM; Roediger MP; Hullsiek KH; Thio CL; Agan BK; Bradley WP; Peel SA; Jagodzinski LL; Weintrob AC; Ganesan A; Wortmann G; Crum-Cianflone NF; Maguire JD; Landrum ML;
    J Infect Dis; 2012 Jan; 205(2):185-93. PubMed ID: 22147794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
    Rana U; Driedger M; Sereda P; Pan S; Ding E; Wong A; Walmsley S; Klein M; Kelly D; Loutfy M; Thomas R; Sanche S; Kroch A; Machouf N; Roy-Gagnon MH; Hogg R; Cooper CL;
    BMC Infect Dis; 2019 Nov; 19(1):982. PubMed ID: 31752729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic and drug- and vaccine-resistance profiles of Hepatitis B Virus among children with HIV co-infection in Pakistan.
    Farooqui N; Mir F; Siddiqui D; Hotwani A; Nathwani AA; Mahmood SF; Sadiq K; Kayani HA; Sheikh SA; Shah SA; Ferrand RA; Abidi SH
    Infect Genet Evol; 2022 Nov; 105():105371. PubMed ID: 36179949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Reconstitution Syndrome with Initiation of Treatment of HBV/HIV Co-infection: Activity Flare associated with E antigen Seroconversion.
    Rowley MW; Patel A; Zhou W; Wong M; Seetharam AB
    Ann Hepatol; 2019; 18(1):220-224. PubMed ID: 31113594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B genotypes: relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia.
    Abdo AA; Al-Jarallah BM; Sanai FM; Hersi AS; Al-Swat K; Azzam NA; Al-Dukhayil M; Al-Maarik A; Al-Faleh FZ
    World J Gastroenterol; 2006 Nov; 12(43):7019-24. PubMed ID: 17109498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.